Joel Block to Adalimumab
This is a "connection" page, showing publications Joel Block has written about Adalimumab.
Connection Strength
0.262
-
Tuberculosis infections and tumor necrosis factor alpha antagonists. Am J Ther. 2013 Jan; 20(1):73-8.
Score: 0.109
-
New therapeutic approaches for spondyloarthritis. Curr Opin Rheumatol. 2007 May; 19(3):259-64.
Score: 0.073
-
Rare infection in patient with rheumatoid arthritis treated with adalimumab. BMJ Case Rep. 2019 Nov 21; 12(11).
Score: 0.044
-
Limited Value of the Multi-Biomarker Disease Activity Assay Compared to the Routine Assessment of Patient Index Data 3 (RAPID3) Score in the Prognosis of Important Clinical Outcomes in Rheumatoid Arthritis: Comment on the Article by Fleischmann et al and Accompanying Editorial by Davis. Arthritis Rheumatol. 2017 04; 69(4):866-867.
Score: 0.036